Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
ID: 353975Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $500K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353975
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at identifying and evaluating potential risk factors for Amyotrophic Lateral Sclerosis (ALS). This initiative seeks investigator-initiated research proposals that focus on various factors, particularly those related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents, with three distinct funding options available to support different types of research. The total estimated program funding is $7.5 million, with individual awards ranging from $0 to $500,000, and the agency anticipates making approximately eight awards. Interested applicants must submit their proposals electronically by November 4, 2024, and can direct inquiries to Candis M. Hunter, PhD, at ncipc_erpo@cdc.gov.

    Point(s) of Contact
    ncipc_erpo@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Studies Addressing Rare Neurodegenerative Diseases including ALS
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for studies addressing rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). This grant aims to support research that advances the development of medical products intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in both adults and children. The initiative is crucial for addressing significant knowledge gaps in the field and is expected to have a substantial impact on the development of interventions for these conditions. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610 for further information. The FDA anticipates awarding approximately 10 grants in fiscal year 2025, with no cost-sharing or matching requirements.
    Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Public Health Strategies to Address Alzheimer's Disease and Related Dementias," aimed at enhancing public health initiatives through cooperative agreements. This initiative seeks to support organizations in developing and implementing strategies that align with the National Healthy Brain Initiative Road Map, focusing on areas such as dementia risk reduction, early detection, and caregiver support. The funding opportunity is critical as Alzheimer's disease is a leading cause of death among older adults in the U.S., and the program aims to build evidence-based practices to improve brain health and support caregivers. Interested applicants can apply for one or more of the three components, with funding amounts ranging from $750,000 to $3 million, and must submit their applications by March 7, 2025. For further inquiries, contact Alisha Etheredge at BOLD@cdc.gov or call 770-488-7884.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Epilepsy Incidence Among Children in the United States
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Epilepsy Incidence Among Children in the United States," aimed at understanding the incidence of epilepsy among U.S. children aged 0 to 17 years. The primary objectives include estimating epilepsy incidence using comprehensive nationwide datasets, identifying risk factors associated with developing epilepsy, and examining disparities in incidence rates across various demographics and social determinants of health. This research is crucial for informing public health policies and resource allocation to improve healthcare services for affected populations. The estimated total program funding is $1.6 million, with a maximum award ceiling of $500,000, and interested applicants must submit their proposals by January 23, 2025. For further inquiries, contact Alison Amoroso at aamoroso@cdc.gov or call 470-395-2521.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.
    Evaluate STEADI-based Fall Prevention in Assisted Living Facilities
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting proposals for a cooperative agreement aimed at evaluating STEADI-based fall prevention strategies in assisted living facilities. The objective is to conduct a well-designed study within two or more facilities that serve diverse populations, particularly focusing on groups with high rates of falls and fall-related injuries, such as Tribal and rural populations, economically disadvantaged individuals, and those with cognitive or physical limitations. This initiative is crucial for enhancing the safety and well-being of older adults (aged 65 and above) in assisted living settings. The total estimated funding for this program is $2.8 million, with a maximum award ceiling of $700,000, and applications must be submitted electronically by December 2, 2024, to be considered. For further inquiries, interested applicants can contact Joyce Dieterly at ncipcerpo@cdc.gov.
    Research Grants to Rigorously Evaluate Innovative and Promising Strategies to Prevent Firearm-Related Violence and Injuries
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering research grants aimed at rigorously evaluating innovative strategies to prevent firearm-related violence and injuries. This funding opportunity seeks investigator-initiated research that addresses various forms of firearm-related incidents, including mass shootings, homicides, suicides, and unintentional injuries, with the goal of enhancing the evidence base for effective prevention strategies. The total estimated program funding is $12.9 million, with an award ceiling of $650,000 and an expected ten awards to be made. Interested applicants must submit their proposals electronically by December 2, 2024, and can direct inquiries to Mikel Walters at ncipcerpo@cdc.gov.
    Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering exploratory and developmental grants (R21) focused on lifestyle medicine research related to the World Trade Center (WTC) Health Program. This funding opportunity aims to support projects that address diagnostic and treatment uncertainties faced by WTC responders and survivors, emphasizing sustainable health behaviors such as nutrition, sleep hygiene, and stress management to improve chronic disease management linked to WTC-related health issues. With an estimated total program funding of $4 million, the CDC anticipates awarding between 4 to 8 grants, each potentially reaching up to $500,000 over two years. Interested applicants must submit their proposals electronically by October 29, 2024, and can direct inquiries to Dr. James Yiin at JYiin@cdc.gov for further information.
    Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation," aimed at enhancing educational resources for families affected by CJD and related prion diseases. The cooperative agreement seeks to provide timely information to families, public health service providers, and health professionals to improve monitoring and understanding of prion diseases, particularly in light of the ongoing chronic wasting disease (CWD) outbreak among deer and elk. Eligible applicants include states, political subdivisions, and nonprofit entities, with funding ranging from $75,000 to a maximum of $100,000, and an estimated total program funding of $500,000. Interested parties should note that applications must be submitted electronically by March 18, 2025, with awards expected to be announced by September 1, 2025; for further inquiries, contact Tracey Ponder at TPonder@cdc.gov or by phone at 404-639-0953.
    Improving well-being for individuals living with a blood disorder through evidence-based programs.
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control - NCBDDD is offering a federal grant opportunity aimed at improving the well-being of individuals living with blood disorders through evidence-based programs. The initiative seeks to enhance the emotional, social, and physical health of affected individuals by promoting mental health literacy and adapting programs that build psychosocial skills, ultimately aiming to reduce morbidity and improve quality of life. With an estimated total program funding of $5,925,000, the agency plans to award four cooperative agreements, with individual awards ranging from $135,000 to $450,000. Interested applicants can reach out to Dr. Fiona Bethea at gvu0@cdc.gov or by phone at 404-639-4033, with applications due by May 15, 2025, and awards expected to be announced by September 1, 2025.